Remove Clinical Development Remove International Remove Treatment
article thumbnail

International Women’s Day: Female life science leaders

Drug Discovery World

For International Women’s Day, DDW’s Diana Spencer celebrates some of the women in leadership making an impact on the drug discovery and life sciences sector. She has managed multinational projects for charities and not-for-profits to find new treatments for Malaria and led Innovate UK grants through to successful completion.

article thumbnail

Drug’s unique mechanism of action targets schizophrenia abnormalities

Drug Discovery World

Newron Pharmaceuticals has reported new findings of mechanism of action that indicate its drug candidate evenamide could be uniquely effective in patients with treatment resistant schizophrenia (TRS).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Patients show 91% response to allogeneic CAR-T therapy

Drug Discovery World

Investigators saw a 91% overall response rate (ORR) in patients with relapsed/refractory multiple myeloma (RRMM) following treatment with allogeneic CAR-T therapy P-BCMA-ALLO1 and lymphodepletion. The therapy is being developed by Poseida Therapeutics and Roche as part of a broader collaboration focused on blood cancers.

Therapies 147
article thumbnail

‘Off-the-shelf’ CAR-T secures FDA advanced therapy designation

Drug Discovery World

P-BCMA-ALLO1 is an investigational stem cell memory T cell (TSCM)-based allogeneic CAR-T cell therapy in Phase I/Ib clinical development for the treatment of patients with relapsed/refractory multiple myeloma.

Therapies 130
article thumbnail

Novo Nordisk announces positive results for haemophilia A?antibody  

Drug Discovery World

Novo Nordisk has announced positive interim results for its Mim8 antibody which is being as a treatment for haemophilia A. . Novo Nordisk presented interim results from the Phase I & II FRONTIER1 dose-escalation study at International Society of Thrombosis and Haemostasis Annual Congress (ISTH 2022) in London, UK.?? .

article thumbnail

Researchers hope to cure HIV using CAR-T cells

Drug Discovery World

The trial is the first-in-human clinical study investigating the duo CAR-T cell therapy for the treatment of HIV. “We So far, there have been no adverse events observed that were related to the treatment and the two participants are doing fine.”

Research 130
article thumbnail

LEO partners with ICON to offer patient-centric dermatology trials

Drug Discovery World

LEO Pharma and ICON have formed a strategic partnership that will enable LEO to offer clinical trials within medical dermatology that are patient-centric and cost effective. The partnership will operate under the acronym of PACE, reflecting the requirement to move quickly to address today’s clinical development challenges.

Trials 130